The protective effect of DNase I in retinal vein occlusion
Retinal vein occlusion (RVO) ranks as the second most prevalent retinal vascular disease, following diabetic retinopathy. Neutrophil extracellular traps (NETs) play an important role in vascular diseases. This study aimed to elucidate the relationship between NETs and RVO, and to discern the potent...
Main Authors: | Guohua Deng, Xi Zou, Zhinan Liu, Hang Ren, Yanting Li, Bin Chen, Jun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2024-03-01
|
Series: | Biomolecules & Biomedicine |
Subjects: | |
Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/9780 |
Similar Items
-
Platelet and Thrombophilia-Related Risk Factors of Retinal Vein Occlusion
by: Adrianna Marcinkowska, et al.
Published: (2021-07-01) -
Platelet-Derived Procoagulant Microvesicles Are Elevated in Patients with Retinal Vein Occlusion (RVO)
by: Adrianna Marcinkowska, et al.
Published: (2022-08-01) -
Targeting NETs using dual-active DNase1 variants
by: Hanna Englert, et al.
Published: (2023-05-01) -
Bilateral Branch Retinal Vein Occlusion after mRNA-SARS-CoV-2 Booster Dose Vaccination
by: Matteo Gironi, et al.
Published: (2023-02-01) -
A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion
by: Shashikant Sharma, et al.
Published: (2020-07-01)